Indication
Non-Erosive Esophageal Reflux Disease
1 clinical trial
2 products
Product
DWP14012Clinical trial
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3, Therapeutic Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-erosive Gastroesophageal Reflux DiseaseStatus: Recruiting, Estimated PCD: 2025-01-01
Product
Placebo